CD34+ acute myeloid and lymphoid leukemic blasts can be induced to differentiate into dendritic cells

Blood

Volumn 94, Issue 6, 1999, Pages 2048-2055

  Cignetti, A ^b   Bryant, E ^b   Allione, B ^b   Vitale, A ^b   Foa, R ^b   Cheever, M A ^a  

^a GLAXOSMITHKLINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; BLAST CELL; CELL DIFFERENTIATION; CELL STRUCTURE; DENDRITIC CELL; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MONOSOMY 7; PHENOTYPE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

EID: 0033568170     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.6.2048.418k21_2048_2055     Document Type: Article

References (31)

1. Cella M, Sallusto F, Lanzavecchia A: Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9:10, 1997
2. Hsu FJ, Benike C, Fagnoni F, Liles TM, Czerwinski D, Taidi B, Engleman EG, Levy R: Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 2:52, 1996
3. Gilboa E, Nair SK, Lyerly HK: Immunotherapy of cancer with dendritic-cell-based vaccines. Cancer Immunol Immunother 46:82, 1998
4. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J: GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 360:258, 1992
5. Bernhard H, Disis ML, Heimfeld S, Hand S, Gralow JR, Cheever MA: Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood. Cancer Res 55:1099, 1995
6. Szabolcs P, Moore MA, Young JW: Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha. J Immunol 154:5851, 1995
7. Freudenthal PS, Steinman RM: The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc Natl Acad Sci USA 87:7698, 1990
8. Sallusto F, Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179:1109, 1994
9. Choudhury A, Gajewski JL, Liang JC, Popat U, Claxton DF, Kliche KO, Andreeff M, Champlin RE: Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia. Blood 89: 1133, 1997
10. Smit WM, Rijnbeek M, van Bergen CA, de Paus RA, Vervenne HA, van de Keur M, Willemze R, Falkenburg JH: Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cells. Hum Immunol 53:216, 1997
11. Eibl B, Ebner S, Duba C, Bock G, Romani N, Erdel M, Gachter A, Niederwieser D, Schuler G: Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the Philadelphia translocation and can induce a CML-specific primary cytotoxic T-cell response. Genes Chromosomes Cancer 20:215, 1997
12. Coleman S, Throp D, Fisher J, Bailey-Wood R, Lim SH: Cytokine enhancement of immunogenicity in chronic myeloid leukaemia. Leukemia 11:2055, 1997
13. Reid CD: The dendritic cell lineage in haemopoiesis. Br J Haematol 96:217, 1997
14. Zhou LJ, Tedder TF: Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol 154:3821, 1995
15. Pinkel D, Straume T, Gray JW: Cytogenetic analysis using quantitative high sensitive fluorescence hybridization. Proc Natl Acad Sci USA 85:9138, 1986
16. Allison JP, Hurwitz AA, Leach DR: Manipulation of costimulatory signals to enhance antitumor T-cell responses. Curr Opin Immunol 7:682, 1995
17. Quo Y, Wu M, Chen H, Wang X, Liu G, Li G, Ma J, Sy MS: Effective tumor vaccine generated by fusion of hepatoma cells with activated B cells. Science 263:518, 1994
18. Gong J, Chen D, Kashiwaba M, Kufe D: Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells. Nat Med 3:558, 1997
19. Wang J, Saffold S, Cao X, Krauss J, Chen W: Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines. J Immunol 161:5516, 1998
20. Law CL, Wormann B, LeBien TW: Analysis of expression and function of CD40 on normal and leukemic human B cell precursors. Leukemia 4:732, 1990
21. Ranheim EA, Kipps TJ: Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J Exp Med 177:925, 1993
22. Renard N, Lafage-Pochitaloff M, Durand I, Duvert V, Coignet L, Banchereau J, Saeland S: Demonstration of functional CD40 in B-lineage acute lymphoblastic leukemia cells in response to T-cell CD40 ligand. Blood 87:5162, 1996
23. Planken EV, Dijkstra NH, Bakkus M, Willemze R, Kluin-Nelemans JC: Proliferation of precursor B-lineage acute lymphoblastic leukaemia by activating the CD40 antigen. Br J Haematol 95:319, 1996
24. Ardavin C, Wu L, Li CL, Shortman K: Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population. Nature 362:761, 1993
25. Marquez C, Trigueros C, Franco JM, Ramiro AR, Carrasco YR, Lopez-Botet M, Toribio ML: Identification of a common developmental pathway for thymic natural killer cells and dendritic cells. Blood 91:2760, 1998
26. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ, Wang ZY: Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72:567, 1988
27. Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ, Corso D, DeBlasio A, Gabrilove J, Scheinberg DA, Pandolfi PP, Warrell RPJ Jr: Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 339:1341, 1998
28. Matulonis U, Dosiou C, Freeman G, Lamont C, Mauch P, Nadler LM, Griffin JD: B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity. Further evidence that B7-1 and B7-2 are functionally distinct. J Immunol 156:1126, 1996
29. Boyer MW, Vallera DA, Taylor PA, Gray GS, Katsanis E, Gorden K, Orchard PJ, Blazar BR: The role of B7 costimulation by murine acute myeloid leukemia in the generation and function of a CD8+ T-cell line with potent in vivo graft-versus-leukemia properties. Blood 89:3477, 1997
30. Costello RT, Mallet F, Sainty D, Maraninchi D, Gastaut JA, Olive D: Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition. Eur J Immunol 28:90, 1998
31. Mutis T, Schrama E, Melief CJ, Goulmy E: CD80-transfected acute myeloid leukemia cells induce primary allogeneic T-cell responses directed at patient specific minor histocompatibility antigens and leukemia-associated antigens. Blood 92:1677, 1998